With a new $1.3 million grant from the NIBIB, researchers led by University of Florida associate professor Zhoumeng Lin are building a tool that can offer drug researchers insight into how well a new nanoparticle-based cancer therapy will work, even before a drug enters animal testing. Source: Nano Magazine.
Explore more about: Synthetic Biological Systems
October 13, 2021
September 14, 2021
Engineers developed a way to grow tiny replicas of the pancreas, using either healthy or cancerous pancreatic cells. Their models could help researchers develop and test potential drugs for pancreatic cancer.
August 31, 2021
Researchers have developed a capsule that can carry large protein drugs, such as monoclonal antibodies, and inject them directly into the lining of the stomach.
August 30, 2021
The human body can be genetically inclined to attack its own cells, destroying the beta cells in the pancreas that make insulin, which helps convert sugar into energy. Called Type 1 diabetes, this disorder can occur at any age and can be fatal if not carefully managed with insulin shots or an insulin pump to balance the body's sugar levels.
August 19, 2021
A Rice University bioengineer and her Brown School of Engineering team were awarded an NIH grant to create gene activity sensors and activators that hold unmatched potential for the treatment of infectious diseases, diabetes, genetic disorders, and cancer. Source: AZO Life Sciences
June 25, 2021
A change of instructions in a computer program directs the computer to execute a different command. Similarly, synthetic biologists are learning the rules for how to direct the activities of human cells.
January 7, 2021
Researchers have successfully used a DNA-editing technique to extend the lifespan of mice with the genetic variation associated with progeria, a rare genetic disease that causes extreme premature aging in children and can significantly shorten their life expectancy.
July 16, 2020
In a groundbreaking new study, researchers have 3D printed a functioning centimeter-scale human heart pump in the lab. The discovery could have major implications for studying heart disease, the leading cause of death in the United States killing more than 600,000 people a year.
May 19, 2020
The Tissue Chips in Space initiative is an ambitious collaborative endeavor that brings NIBIB, NCATS, and the ISS U.S. National Laboratory together to rapidly advance tissue chip technology for biomedical research.
November 25, 2019
Researchers have designed a more precise and versatile genome editing system, named prime editing, that harnesses the power of CRISPR-Cas9 in combination with another protein, reverse transcriptase, to directly edit DNA in human cells.